Nucleotides - Part LIX - Synthesis, characterization, and biological activities of new potential antiviral agents: (2 '-5 ')adenylate trimer analogs containing 3 '-deoxy-3 '(hexadecanoylamino)adenosine at the 2 '-terminus

Citation
H. Schirmeister-tichy et al., Nucleotides - Part LIX - Synthesis, characterization, and biological activities of new potential antiviral agents: (2 '-5 ')adenylate trimer analogs containing 3 '-deoxy-3 '(hexadecanoylamino)adenosine at the 2 '-terminus, HELV CHIM A, 82(4), 1999, pp. 597-613
Citations number
39
Categorie Soggetti
Chemistry & Analysis",Chemistry
Journal title
HELVETICA CHIMICA ACTA
ISSN journal
0018019X → ACNP
Volume
82
Issue
4
Year of publication
1999
Pages
597 - 613
Database
ISI
SICI code
0018-019X(1999)82:4<597:N-PL-S>2.0.ZU;2-P
Abstract
Based upon 3'-amino-3'-deoxyadenosine (15), its protected 3'-hexadecanoylam ino derivative 22 was chosen as starting material for the synthesis of a se ries of new modified 2'-5'-adenylate trimers 33-36 as potential antiviral a gents. All (2'-5')A trimer analogs 33-36 inhibit HIV-1 replication as measu red by the inhibition of syncytia formation and inhibition of HIV-1 reverse transcriptase activity. Compound 34 inhibits HIV-1 reverse transcription b y 100% and subsequently inhibits expression of HIV-1 p24. However, compound 35 acts differently, since it does not inhibit HIV-1 reverse transcription , HIV-1 integrase, or HIV-1 p24 expression. Therefore, 35 appears to exert its inhibitory effect at a later stage of HIV-1 replication, i.e., the budd ing process.